Cite
HARVARD Citation
Cencini, E. et al. (2019). Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab. British journal of haematology. pp. 223-231. [Online].